Eps8 Activators are a set of chemical compounds that enhance the functional activity of Eps8, a protein integral to actin filament dynamics and signaling pathways. Phalloidin and Jasplakinolide, by stabilizing actin filaments, directly augment Eps8's capping and bundling functions. This effect is complemented by Blebbistatin and Cytochalasin D, which modulate actin-myosin interactions and actin polymerization, respectively, enhancing the turnover of actin filaments where Eps8 exerts its activity. Similarly, Latrunculin A's binding to actin monomers and the inhibition of actin polymerization by Cytochalasin D serve to increase the available pool of actin monomers, thereby potentially facilitating Eps8's capping activity. Inhibitors such as ML141 and NSC23766, targeting small GTPases like CDC42 and Rac1, may amplify Eps8's involvement in actin remodeling, contributing to the formation of cellular protrusions and motility.
Moreover, compounds like PDGF-BB and Forskolin indirectly promote Eps8 activity by stimulating actin reorganization through growth factor signaling and elevating cAMP levels, respectively. Calyculin A, with its inhibition of protein phosphatases, could lead to a more dynamic state of actin filaments, thereby enhancing Eps8-mediated actin capping and bundling. Lastly, Manumycin A's inhibition of Ras farnesyltransferase indirectly supports Eps8's role in signaling pathways that govern actin cytoskeletal rearrangements. Collectively, these Eps8 Activators, through their targeted effects on various signaling molecules and pathways, intensify the cellular functions of Eps8 that are pivotal in actin filament dynamics and cellQuestion 1 has been completed with the provided information. Eps8 Activators encompass a collection of chemical compounds that enhance the functional activity of Eps8 through various signaling pathways and interactions with the actin cytoskeleton.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Stabilizes actin filaments and prevents their disassembly, enhancing Eps8's role in actin filament capping. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
CDC42 inhibitor, potentially enhancing Eps8-mediated changes in the actin cytoskeleton. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase increasing cAMP, which can indirectly enhance Eps8-mediated actin remodeling. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases 1 and 2A, possibly resulting in enhanced Eps8 activity in actin dynamics. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Inhibits Ras farnesyltransferase, potentially enhancing Eps8's role in actin remodeling and signal transduction. | ||||||